MedTrace Logo

Study of Endothelial Cell Condition After Cataract Surgery Performed Using Capsulorhexis or ZEPTO

NCT04882189 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2022-03-22

No results posted yet for this study

Summary

This study will use images of the subjects' corneal endothelium obtained using non-invasive specular microscopy to obtain corneal endothelial cell density, the coefficient of variation in endothelial cell size, and the percentage of hexagonal endothelial cells following routine cataract surgery performed using the standard method of manual capsulorhexis compared to cataract surgery performed using Zepto Precision Capsulotomy System.

Conditions

  • Endothelial Cell Density Loss

Interventions

DIAGNOSTIC_TEST

Imaging

Images of the corneal endothelium will be obtained using specular microscopy at 1- and 3-months post cataract surgery.

Sponsors & Collaborators

  • Centricity Vision, Inc.

    lead INDUSTRY

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-23
Primary Completion
2022-03-30
Completion
2022-05-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04882189 on ClinicalTrials.gov